Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1333> Maruha Nichiro 2969 3106 <1429> Japan Aqua 964 1059 <1766> Token Corpo 10380 10860 <1815> Tetsuken 2641 2800 <1820> Nishimatsu Ken
Nikkei average contribution ranking (advance closing) ~ The Nikkei average rebounded for the first time in 4 days, and Advantest boosted by about 57 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 18 days ago was 187 stocks with price increases, 38 stocks with price drops, and 0 stocks unchanged. The Nikkei Average rebounded for the first time in 4 days. The front-end transaction was closed at 38090.87 yen (estimated turnover of 760 million shares), which is 129.07 yen higher (+0.34%) compared to the previous day. The US market declined on the 17th. The Dow average depreciated by $45.66 (-0.12%) to $37753.31, and the Nasdaq depreciated 181.88 points (-1.15%) to 15683
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associated with Alzheimer's.The data demonstrates a clinically significant
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1333> Maruha Nichiro 3056 2908 <1721> Comsys HD 3607 3399 <1766> Token Corpo 10610 10220 <1888> Wakachiken 3675 3485 <1928> Sekisui House
Vertex Pharma Upgraded at Evercore on Alpine Immune Deal
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 4/9)
<1439>[Good Material] ――――――――――■Yasue Corporation [Tokyo Stock Exchange S] March order volume increased 10.7% from the same month last year, surpassing the previous year's results for the first time in 2 months. ■Tabio <2668>[Tokyo Stock Exchange S]'s current financial results for the current fiscal year will increase 11%. ■Can Do <2698>[Tokyo Stock Exchange S] Current fiscal year earnings will increase 69%. ■Pal Group Holdings <2726>[Tokyo Stock Exchange P]'s current financial results increased 8% to the highest profit for the 3rd consecutive term. <2923>■Sato Foods [Tokyo Stock Exchange
At the forefront of “Brain Tech”! List of elite stocks winning through fierce development competition <Stock Search Top Feature>
Development competition in the “brain tech” field, which combines neuroscience with cutting-edge technology, is extremely fierce. Startup companies have sprung up one after another in Japan and overseas, and new products and services have appeared, and listed companies are also advancing research and development in anticipation of future commercialization in a market where rapid growth can be expected. It seems that it can be said that related stocks are in a state where energy to undergo transformation is contained.
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation
Otsuka Holdings (TYO:4578) is disposing of its treasury shares, involving 363,900 common shares valued at 6,382 yen each, or 2.32 billion yen in total, according to its bourse filing on Thursday. The
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <2922> Natori 2114 2179 <2931> Euglena 605 641 <3002> Gunze 5420 5680 <3036> Alconix 1435 1496 <3087> Doutor Day Less
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation in Dementia from Alzheimer's Disease (AAD).The interim data demo
Jefferies Adjusts Otsuka Holdings' Price Target to 7,400 Yen From 6,800 Yen, Keeps at Buy
05:25 AM EDT, 03/18/2024 (MT Newswires) -- Jefferies Adjusts Otsuka Holdings' Price Target to 7,400 Yen From 6,800 Yen, Keeps at Buy
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses
Otsuka Holdings' (TYO:4578) profit attributable to owners of the parent fell 9.2% to 121.62 billion yen in the year ended Dec. 31, 2023, from 133.91 billion yen a year ago mainly due to wider impairme
Otsuka Holdings Sees FY Net Y250.00B
Otsuka Holdings Co. Ltd. also released the following forecasts: GROUP 1st Half To Year Ending Jun 2024 Dec 2024 Revenue Y1.04 tln Y2.14 t
Otsuka Holdings Lowers 2023 Profit Outlook
Otsuka Holdings (TYO:4578) revised its consolidated financial forecasts to factor in its bigger-than-expected revenue and impairment losses. The pharmaceutical company said revenue across all business
Otsuka Holdings Cuts FY Net View to Y121.00B
GROUP New Forecast Prior For Year To Dec 2023 Forecast Operating Profit Y139.00 bln Y245.00 bln Pretax Profit N/A
Phase 3 Trial for Otsuka's Alzheimer's-related Agitation Treatment Fails to Meet Primary Endpoint
Otsuka Pharmaceutical (TYO:4578) and its US subsidiaries have disclosed the top-line results of their phase 3 trial for AVP-786, which failed to show a significant difference in the treatment of agita
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026
MicroPort Scientific (HKG:0853) agreed to keep Thai Otsuka Pharmaceutical as the distributor for the group's medical devices in Thailand for three more years. Thai Otsuka, a unit of Otsuka Holdings (T
Otsuka Unit Buys New York-Based Provider of Women Health Products
Otsuka Holdings' (TYO:4578) California subsidiary Pharmavite acquired Bonafide Health, a New York-based provider of women's health products. Financial terms weren't disclosed in the Dec. 1 bourse fili
Nomura Adjusts Otsuka Holdings' Price Target to 6,800 Yen From 6,500 Yen, Keeps at Buy
05:26 AM EST, 11/29/2023 (MT Newswires) -- Nomura Adjusts Otsuka Holdings' Price Target to 6,800 Yen From 6,500 Yen, Keeps at Buy
Jefferies: Investor Interest Shifts From Daiichi Sankyo to Chugai and Otsuka Holdings
Daiichi Sankyo (TYO:4568), traditionally a favorite healthcare stock among investors in Japan, has seen a decrease in popularity, according to a Jefferies report on Monday. The decline in holders of D
No Data